Action Alerts

 


Archived Action Alerts

 

Senate Sign-On Letter: Support Increased Funding to Combat Viral Hepatitis and Opioid-Related Infectious Diseases

(April 2019) Similar to the letter that circulated in the House of Representatives last month, Senator Mazie Hirono is also leading a sign-on letter in the Senate regarding the need for increased funding to combat viral hepatitis and opioid-related infectious diseases. This letter will be sent to the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies, requesting that the Fiscal Year 2020 appropriations bill includes $134 million for viral hepatitis programs at the Centers for Disease Control and Prevention (CDC) and include $58 million to fully fund resources included in the recently passed SUPPORT for Patients and Communities Act to eliminate opioid-related infectious diseases. Please email and/or call your Senators and urge them to sign on!


Congressional Sign-On Letter: Support for Deployability of Servicemembers with HBV, HCV, and HIV

(March 2019) Rep. Jackie Speier is leading a Congressional sign-on letter in the House to support the deployability of servicemembers with living with hepatitis B (HBV), hepatitis C (HCV), and HIV. This letter will be sent to the Department of Defense, urging them to implement its “Deploy or Discharge” policy with reason and flexibility to ensure that every able servicemember, including those living with HBV, can continue to serve. Please email and/or call your Representative today and urge them to sign on!


Congressional Sign-On Letter: Support Increased Funding to Combat Viral Hepatitis and Opioid-Related Infectious Diseases

(March 2019) The co-chairs of the Congressional Hepatitis Caucus, Reps. Grace Meng and Hank Johnson, are circulating a sign-on letter in the House regarding the need for increased funding to combat viral hepatitis and opioid-related infectious diseases. This letter will be sent to the Labor, Health and Human Services, Education, and Related Agencies Appropriations Subcommittee, requesting that the Fiscal Year 2020 appropriations bill includes $134 million for viral hepatitis programs at the Centers for Disease Control and Prevention (CDC), and at least $58 million to fully fund a recently passed program to eliminate opioid-related infectious diseases. Please email and/or call your Representative today and urge them to sign on!

Ask Congress to Support Liver Disease Awareness, Prevention, and Research Initiatives

(October 2018) On October 12th, Congresswoman Nydia Velazquez (D-NY) introduced the Liver Illness, Visibility, Education, and Research (LIVER) Act of 2018. The bill takes bold steps to increase investments in research, prevention, and awareness activities to address liver cancer, the second deadliest cancer in the United States and worldwide, as well as its major risk factors, including hepatitis B. The full text of the bill, H.R. 7063, is available hereWe need your help contacting more Members of Congress to encourage them to co-sponsor this legislation and continue moving it forward!


Stop the DOD from Discharging Service Members with Hepatitis B

(September 2018) The careers of service members who are medically "non-deployable," including 695 DOD personnel living with chronic hepatitis B (HBV), are at risk come October 1st, when the DOD implements a new “Deploy or Discharge” policy. Diagnosed with chronic HBV years after they entered military service, the “non-deployable” classification of these service members is the result of outdated HBV policies and DOD’s failure to document science and evidence-based HBV regulations.